211 related articles for article (PubMed ID: 25919182)
21. Strengthening vaccination policies in Latin America: an evidence-based approach.
Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
[TBL] [Abstract][Full Text] [Related]
22. Health economics of rotavirus immunization in Vietnam: potentials for favorable cost-effectiveness in developing countries.
Tu HA; Rozenbaum MH; Coyte PC; Li SC; Woerdenbag HJ; Postma MJ
Vaccine; 2012 Feb; 30(8):1521-8. PubMed ID: 22119590
[TBL] [Abstract][Full Text] [Related]
23. Strategies for financial sustainability of immunization programs: a review of the strategies from 50 national immunization program financial sustainability plans.
Kamara L; Milstien JB; Patyna M; Lydon P; Levin A; Brenzel L
Vaccine; 2008 Dec; 26(51):6717-26. PubMed ID: 18955100
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness analysis of introducing universal human papillomavirus vaccination of girls aged 11 years into the National Immunization Program in Brazil.
Novaes HM; de Soárez PC; Silva GA; Ayres A; Itria A; Rama CH; Sartori AM; Clark AD; Resch S
Vaccine; 2015 May; 33 Suppl 1():A135-42. PubMed ID: 25919154
[TBL] [Abstract][Full Text] [Related]
25. How much does it cost to get a dose of vaccine to the service delivery location? Empirical evidence from Vietnam's Expanded Program on Immunization.
Mvundura M; Kien VD; Nga NT; Robertson J; Cuong NV; Tung HT; Hong DT; Levin C
Vaccine; 2014 Feb; 32(7):834-8. PubMed ID: 24370713
[TBL] [Abstract][Full Text] [Related]
26. Financing And Funding Gap For 16 Vaccines Across 94 Low- And Middle-Income Countries, 2011-30.
Sriudomporn S; Sim SY; Mak J; Brenzel L; Patenaude BN
Health Aff (Millwood); 2023 Jan; 42(1):94-104. PubMed ID: 36623227
[TBL] [Abstract][Full Text] [Related]
27. Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries.
Goldie SJ; O'Shea M; Campos NG; Diaz M; Sweet S; Kim SY
Vaccine; 2008 Jul; 26(32):4080-93. PubMed ID: 18550229
[TBL] [Abstract][Full Text] [Related]
28. The drivers of facility-based immunization performance and costs. An application to Moldova.
Maceira D; Goguadze K; Gotsadze G
Vaccine; 2015 May; 33 Suppl 1():A72-8. PubMed ID: 25919179
[TBL] [Abstract][Full Text] [Related]
29. Second National Immunization Congress 2010: addressing vaccine financing for the future in the US.
Shen AK; Sobzcyk E; Buchanan A; Wu L; Duggan-Goldstein S
Hum Vaccin; 2011 Jan; 7(1):12-8. PubMed ID: 21178397
[TBL] [Abstract][Full Text] [Related]
30. Gaps in vaccine financing for underinsured children in the United States.
Lee GM; Santoli JM; Hannan C; Messonnier ML; Sabin JE; Rusinak D; Gay C; Lett SM; Lieu TA
JAMA; 2007 Aug; 298(6):638-43. PubMed ID: 17684186
[TBL] [Abstract][Full Text] [Related]
31. Costs of introducing pneumococcal, rotavirus and a second dose of measles vaccine into the Zambian immunisation programme: Are expansions sustainable?
Griffiths UK; Bozzani FM; Chansa C; Kinghorn A; Kalesha-Masumbu P; Rudd C; Chilengi R; Brenzel L; Schutte C
Vaccine; 2016 Jul; 34(35):4213-4220. PubMed ID: 27371102
[TBL] [Abstract][Full Text] [Related]
32. The cost structure of routine infant immunization services: a systematic analysis of six countries.
Geng F; Suharlim C; Brenzel L; Resch SC; Menzies NA
Health Policy Plan; 2017 Oct; 32(8):1174-1184. PubMed ID: 28575193
[TBL] [Abstract][Full Text] [Related]
33. Estimating the costs of implementing the rotavirus vaccine in the national immunisation programme: the case of Malawi.
Madsen LB; Ustrup M; Hansen KS; Nyasulu PS; Bygbjerg IC; Konradsen F
Trop Med Int Health; 2014 Feb; 19(2):177-85. PubMed ID: 24314006
[TBL] [Abstract][Full Text] [Related]
34. Tracking donor funding towards achieving the Global Vaccine Action Plan (GVAP) goals: A landscape analysis (1990-2016).
Ikilezi G; Zlavog B; Augusto OJ; Sherr K; Lim SS; Dieleman JL
Vaccine; 2018 Nov; 36(49):7487-7495. PubMed ID: 30366804
[TBL] [Abstract][Full Text] [Related]
35. 78 countries: immunization financing in developing and transitional countries.
Deroeck D; Levin A
Health Reform Prior Serv; 1999; ():21-4. PubMed ID: 12222166
[TBL] [Abstract][Full Text] [Related]
36. Applying lessons learned from the USAID family planning graduation experience to the GAVI graduation process.
Shen AK; Farrell MM; Vandenbroucke MF; Fox E; Pablos-Mendez A
Health Policy Plan; 2015 Jul; 30(6):687-95. PubMed ID: 24974106
[TBL] [Abstract][Full Text] [Related]
37. EPIVAC International Conference on Financial Sustainability of Immunization Programs in sub-Saharan Africa, February 16-18, 2012, Ouidah, Benin.
Drach M; Le Gargasson JB; Mathonnat J; Da Silva A; Kaddar M; Colombini A
Vaccine; 2013 Sep; 31(41):4470-6. PubMed ID: 23892101
[TBL] [Abstract][Full Text] [Related]
38. The cost determinants of routine infant immunization services: a meta-regression analysis of six country studies.
Menzies NA; Suharlim C; Geng F; Ward ZJ; Brenzel L; Resch SC
BMC Med; 2017 Oct; 15(1):178. PubMed ID: 28982358
[TBL] [Abstract][Full Text] [Related]
39. Perspectives on expanding the evidence base to inform vaccine introduction: Program costing and cost-effectiveness analyses.
Andrus JK; Walker DG
Vaccine; 2015 May; 33 Suppl 1():A2-3. PubMed ID: 25919161
[No Abstract] [Full Text] [Related]
40. Determinants of routine immunization costing in Benin and Ghana in 2011.
Ahanhanzo CD; Huang XX; Le Gargasson JB; Sossou J; Nyonator F; Colombini A; Gessner BD
Vaccine; 2015 May; 33 Suppl 1():A66-71. PubMed ID: 25919178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
